IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of IRIDEX (NASDAQ:IRIX) in a report published on Sunday morning. The firm issued a hold rating on the medical equipment provider’s stock.

IRIDEX Stock Performance

Shares of IRIX opened at $1.23 on Friday. The firm has a 50-day moving average of $1.57 and a 200-day moving average of $1.68. IRIDEX has a one year low of $1.16 and a one year high of $3.65. The company has a market cap of $20.46 million, a PE ratio of -1.84 and a beta of 0.94. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.54 and a quick ratio of 0.85.

About IRIDEX

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.